Clinical Trials Directory

Trials / Completed

CompletedNCT02375854

Outcomes of Neonatal Acute Kidney Injury In Premature Infants

Outcomes of Neonatal Acute Kidney Injury and Prematurity: An Observational Study and Einstein-Montefiore Neonatal Acute Kidney Injury Clinical Registry and Biorepository

Status
Completed
Phase
Study type
Observational
Enrollment
25 (actual)
Sponsor
Montefiore Medical Center · Academic / Other
Sex
All
Age
1 Day – 5 Years
Healthy volunteers
Accepted

Summary

The objective of this protocol is to investigate the impact of prematurity, with or without associated acute kidney injury (AKI), on the future risk of chronic kidney disease (CKD) by establishing a patient registry and biorepository. Serum and urine samples will be collected serially from premature infants admitted to the neonatal intensive care unit (NICU) at Albert Einstein College of Medicine/Weiler Hospital and subsequently followed in the NICU follow-up and pediatric nephrology ambulatory subspecialty clinics. The biorepository will be linked to a comprehensive clinical database.

Detailed description

This is an observational pilot study to enhance understanding of the pathophysiology and epidemiology associated with effects of AKI in premature infants and the role that neonatal AKI plays in future development of CKD. In eligible preterm infants, blood and urine samples will be collected at pre-specified time points during hospitalization and at outpatient follow-up appointments at 6 months, 1 year, 2 years, and 5 years of age and stored in the biorepository. Blood pressure will be measured and recorded at NICU discharge and at all follow-up visits. A renal ultrasound will be performed to monitor renal growth at 2 and 5 years of age. All data will be entered into a comprehensive clinical database, including laboratory results.

Conditions

Interventions

TypeNameDescription
OTHERObservation

Timeline

Start date
2014-11-01
Primary completion
2024-08-30
Completion
2024-08-30
First posted
2015-03-03
Last updated
2024-09-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02375854. Inclusion in this directory is not an endorsement.